Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combing a Deep Learning-Based MRI Multimodal Radiomics Method With Liquid Biopsy Technique for Preoperative and Non-invasive Diagnosis of Glioma Grading and Molecular Subtype

NCT05536024 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.

NCT NCT05536024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05536024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combing a Deep Learning-Based MRI Multimodal Radiomics Method With Liquid Biopsy Technique for Preoperative and Non-invasive Diagnosis of Glioma Grading and Molecular Subtype
Lead sponsor
Second Affiliated Hospital of Nanchang University
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2022
Completion date
August 30, 2023
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

deep learning, glioma (diagnosis), liquid biopsy